Intrinsic Value of S&P & Nasdaq Contact Us

Echo Therapeutics, Inc. ECTE OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
32/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ECTE

Echo Therapeutics, Inc. (ECTE) and trades at $0.00. The 52-week range is 0.0002-0.0002.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.98.

The stock has a beta of 6.78, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0002-0.0002
Volume5.08K
Avg Volume (30D)8.09K
Beta (1Y)6.78
Company
IPO Date2022-01-31
Employees19
CEOAlan W. Schoenbart CPA
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS27876L2060
CUSIP27876L206
Income (Latest Year)
EBITDA$-21.66M
Operating Income$-7.64M
Net Income$-22.2M
EPS$-1.98
EPS Diluted$-1.98
Shares Outstanding$11.23M
Balance Sheet (Latest Year)
Total Assets$805.09K
Current Assets$300.74K
Cash & ST Investments$56.21K
Total Liabilities$3.33M
Total Debt$330K
Net Debt$273.79K
Total Equity$-2.53M
Debt / Equity-0.13
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message